Evidence map›Paper›PMID 21437236›Full record

ArticlePloS one2011

A20 modulates lipid metabolism and energy production to promote liver regeneration.

Scott M Damrauer, Peter Studer, Cleide G da Silva, Christopher R Longo, Haley E Ramsey, Eva Csizmadia, Gautam V Shrikhande, Salvatore T Scali, Towia A Libermann, Manoj K Bhasin and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Key hepatoprotective roles of mitochondria in liver regeneration.American journal of physiology. Gastrointestinal and liver physiology · 2023
    Review
  6. Fibrosis and hepatic regeneration mechanism.Translational gastroenterology and hepatology · 2022
    Review
  7. Review
  8. A20 at the Crossroads of Cell Death, Inflammation, and Autoimmunity.Cold Spring Harbor perspectives in biology · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. A20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomes.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2015
    Article
  18. Genomics of liver transplant injury and regeneration.Transplantation reviews (Orlando, Fla.) · 2015
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Scott M DamrauerDivision of Vascular Surgery, and the Transplant Institute, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
Peter Studer
Cleide G da Silva
Christopher R Longo
Haley E Ramsey
Eva Csizmadia
Gautam V Shrikhande
Salvatore T Scali
Towia A Libermann
Manoj K Bhasin
Christiane Ferran
Beth Israel Deaconess Medical Center · USCenter for Vascular Biology Research · USHarvard University · US

Funding

HARVARD-LONGWOOD RESEARCH TRAINING IN VASCULAR SURGERYT32HL007734 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FERRAN, CHRISTIANE, LOGERFO, FRANK W · 1993 to 2023
$10.5M
Improved liver function and regeneration with A20R01DK063275 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FERRAN, CHRISTIANE · 2003 to 2013
$3.7M
Vascular Remodeling in Transplant ArteriosclerosisR01HL080130 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FERRAN, CHRISTIANE · 2006 to 2009
$1.7M
MODULATION OF ENDOTHELIAL CELL RESPONSES BY A20R01HL057791 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FERRAN, CHRISTIANE · 1998 to 2001
$581k
NHLBI NIH HHS HL057791NHLBI NIH HHS R01 HL080130NHLBI NIH HHS T32 HL007734NHLBI NIH HHS T32 HL07734NIDDK NIH HHS R01 DK063275
6 · The paper itself

Abstract

backgroundLiver regeneration is clinically of major importance in the setting of liver injury, resection or transplantation. We have demonstrated that the NF-κB inhibitory protein A20 significantly improves recovery of liver function and mass following extended liver resection (LR) in mice. In this study, we explored the Systems Biology modulated by A20 following extended LR in mice. METHODOLOGY AND PRINCIPAL

findingsWe performed transcriptional profiling using Affymetrix-Mouse 430.2 arrays on liver mRNA retrieved from recombinant adenovirus A20 (rAd.A20) and rAd.βgalactosidase treated livers, before and 24 hours after 78% LR. A20 overexpression impacted 1595 genes that were enriched for biological processes related to inflammatory and immune responses, cellular proliferation, energy production, oxidoreductase activity, and lipid and fatty acid metabolism. These pathways were modulated by A20 in a manner that favored decreased inflammation, heightened proliferation, and optimized metabolic control and energy production. Promoter analysis identified several transcriptional factors that implemented the effects of A20, including NF-κB, CEBPA, OCT-1, OCT-4 and EGR1. Interactive scale-free network analysis captured the key genes that delivered the specific functions of A20. Most of these genes were affected at basal level and after resection. We validated a number of A20's target genes by real-time PCR, including p21, the mitochondrial solute carriers SLC25a10 and SLC25a13, and the fatty acid metabolism regulator, peroxisome proliferator activated receptor alpha. This resulted in greater energy production in A20-expressing livers following LR, as demonstrated by increased enzymatic activity of cytochrome c oxidase, or mitochondrial complex IV.

conclusionThis Systems Biology-based analysis unravels novel mechanisms supporting the pro-regenerative function of A20 in the liver, by optimizing energy production through improved lipid/fatty acid metabolism, and down-regulated inflammation. These findings support pursuit of A20-based therapies to improve patients' outcomes in the context of extreme liver injury and extensive LR for tumor treatment or donation.

Indexed as

Energy MetabolismLipid MetabolismAnimalsBinding SitesCell ProliferationDNA-Binding ProteinsGene Expression RegulationGene Regulatory NetworksHepatocytesHumansInflammationIntracellular Signaling Peptides and ProteinsLiverLiver RegenerationMiceNuclear ProteinsDNA-Binding ProteinsIntracellular Signaling Peptides and ProteinsNuclear ProteinsTNFAIP3 protein, humanTranscription FactorsTumor Necrosis Factor alpha-Induced Protein 3

Identifiers

PMID21437236
PMCPMC3060102
OpenAlexW2094679544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.